C16H19F2NO4
Neat
327.33
1, 1-Dimethylethyl N-[(2R, 3S)-2-(2, 5-difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamate; tert-butyl((2R, 3S)-2-(2, 5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate; tert-butyl[(2R, 3S)-2-(2, 5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl]carbamate; 1, 1-Dimethylethyl N-((2R, 3S)-2-(2, 5-difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl)carbamate; RefChem:896504; 691-744-0; 951127-25-6; tert-butyl ((2R, 3S)-2-(2, 5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbamate; MFCD20926096; tert-butyl N-[(2R, 3S)-2-(2, 5-difluorophenyl)-5-oxooxan-3-yl]carbamate; tert-Butyl N-[(2R, 3S)-2-(2, 5-difluorophenyl)-5-oxo-tetrahydropyran-3-yl]carbamate; N-[(2R, 3S)-2-(2, 5-Difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamic acid 1, 1-dimethylethyl ester; N-[(2R, 3S)-2-(2, 5-difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]-CarbaMic acid 1, 1-diMethylethyl ester; Cpo3604-01; tert-butyl [(2R, 3S)-2-(2, 5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl]carbamate; OTCULXVRRSCLLI-UONOGXRCSA-N; N-?[(2S, ?3S)?-?2-?(2, ?5-Difluorophenyl)?tetrahydro-?5-?oxo-?2H-?pyran-?3-?yl]?carbamic acid?, 1, ?1-Ddimethylethyl Ester; Omarigliptin Impurity 3; MK-3102 intermediate; tert-butyl [(2R, 3S)-5-oxo-2-(2 and 5-difluorophenyl)tetradihydro-2H-pyran-3-yl]carbaMate
tert-butyl N-[(2R, 3S)-2-(2 and 5-difluorophenyl)-5-oxooxan-3-yl]carbamate
InChI=1S/C16H19F2NO4/c1-16(2,3)23-15(21)19-13-7-10(20)8-22-14(13)11-6-9(17)4-5-12(11)18/h4-6,13-14H,7-8H2,1-3H3,(H,19,21)/t13-,14+/m0/s1